Summary
Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The North American pharmaceuticals market had total revenues of $437.0m in 2018, representing a compound annual growth rate (CAGR) of 4.4% between 2014 and 2018.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.2% for the five-year period 2018-2023, which is expected to drive the market to a value of $535.6m by the end of 2023.
- The US is by far the largest market in the region, and maintains good growth consistently despite its developed nature due to the very strong private health sector.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the North America pharmaceuticals market by value in 2018?
- What will be the size of the North America pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the North America pharmaceuticals market?
- How has the market performed over the last five years?
- How large is North America’s pharmaceuticals market in relation to its regional counterparts?
'
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: North America pharmaceuticals market value: $ billion, 2014-18
Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: North America pharmaceuticals market share: % share, by value, 2018
Table 4: North America pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Johnson & Johnson: key facts
Table 9: Johnson & Johnson: key financials ($)
Table 10: Johnson & Johnson: key financial ratios
Table 11: Merck & Co., Inc.: key facts
Table 12: Merck & Co., Inc.: key financials ($)
Table 13: Merck & Co., Inc.: key financial ratios
Table 14: Pfizer Inc: key facts
Table 15: Pfizer Inc: key financials ($)
Table 16: Pfizer Inc: key financial ratios
List of Figures
Figure 1: North America pharmaceuticals market value: $ billion, 2014-18
Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: North America pharmaceuticals market share: % share, by value, 2018
Figure 4: North America pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in North America, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in North America, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in North America, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2018
Figure 11: AstraZeneca PLC: revenues & profitability
Figure 12: AstraZeneca PLC: assets & liabilities
Figure 13: Johnson & Johnson: revenues & profitability
Figure 14: Johnson & Johnson: assets & liabilities
Figure 15: Merck & Co., Inc.: revenues & profitability
Figure 16: Merck & Co., Inc.: assets & liabilities
Figure 17: Pfizer Inc: revenues & profitability
Figure 18: Pfizer Inc: assets & liabilities
